The Intermountain Healthcare-backed healthcare data software provider's total funding stands at $95m following its series D round.

University of Alberta spinout Tevosol has been picked up by Bridge to Life but will maintain its base in Edmonton.

Taiho Ventures co-led a series A round for the MIT spinout, which was incubated by MPM Capital.

Taiho Ventures co-led a series A round for the oRNA technology developer, which also attracted Astellas, Kite, BMS and Novartis.

The Suzhong Pharma and China Construction Bank-backed cancer drug developer is gearing up for an initial public offering after securing a new capital injection.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

SoftBank Investment Advisers contributed to a round for the cancer and immune disorder drug developer co-led by Logos Capital and Boxer Capital.

Strategic partner Thermo Fisher Scientific was among the participants in a series B round for the diagnostics technology producer.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Azeria Therapeutics has wound down voluntarily four years after being set up to advance University of Cambridge and Cancer Research UK work.